Trial Profile
The UK Collaborative HIV Cohort Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals; Atazanavir; Lopinavir
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms UK CHIC
- 16 Feb 2022 Results from this and other study compared virological suppression and all-cause mortality between different InSTI- and non-InSTI-based regimens among PWH starting ART in Europe and North America, presented at the 29th Conference on Retroviruses and Opportunistic Infections
- 20 Feb 2017 Results of subgroup analysis assessing kidney function in patients who switched from atazanavir or lopinavir to darunavir published in the AIDS.
- 24 Jan 2017 Results (n=15983) assessing risk factors of developing severe renal tubulopathy in patients treated with tenofovir disoproxil fumarate, published in the Journal of Infection